WHO pointers demand manufacturers to put into action a continuous possibility administration approach for sterility test isolators, such as frequent chance assessments and the development of possibility-primarily based Command techniques. Manufacturers trying to apply these solutions have to supply strong validation info to demonstrate their equivalence to pharmacopoeial methods. waiting for link from Forum Profiles (6)